Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling

NCT02407327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 215

Last updated 2023-11-01

No results posted yet for this study

Summary

The purpose of this study is to determine the percentage of CTC-positive patients and total CTC numbers in patients with advanced Non Small Cell Lung Cancer .

Conditions

  • Advanced Non Small Cell Lung Cancer

Sponsors & Collaborators

  • Ministry of Health, Italy

    collaborator OTHER_GOV
  • Istituto Oncologico Veneto IRCCS

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-01
Primary Completion
2016-12-01
Completion
2016-12-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407327 on ClinicalTrials.gov